Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells

Journal of Immunology

Volumn 173, Issue 4, 2004, Pages 2462-2469

  Liao, Yu Pei ^a   Wang, Chun Chieh ^a,d   Butterfield, Lisa H ^b   Economou, James S ^a   Ribas, Antoni ^a   Meng, Wilson S ^c   Iwamoto, Keisuke S ^a   McBride, William H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c DUQUESNE UNIVERSITY   (United States)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MELAN A;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; IONIZING RADIATION; LYMPHOCYTE; MELANOCYTE; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; TUMOR GROWTH; TUMOR IMMUNITY;

EID: 4043142149     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.4.2462     Document Type: Article

References (65)

1. North, R. J. 1984. γ-Irradiation facilitates the expression of adoptive immunity against established tumors by eliminating suppressor T cells. Cancer Immunol. Immunother. 16:175.
2. Klinkert, W. E., J. H. LaBadie, and W. E. Bowers. 1982. Accessory and stimulating properties of dendritic cells and macrophages isolated from various rat tissues. J. Exp. Med. 156:1.
3. Kawase, Y., S. Naito, M. Ito, I. Sekine, and H. Fujii. 1990. The effect of ionizing radiation on epidermal Langerhans cells: a quantitative analysis of autopsy cases with radiation therapy. J. Radiat. Res. 31:246.
4. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
5. Cella, M., F. Sallusto, and A. Lanzavecchia. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9:10.
6. Stingl, G., and P. R. Bergstresser. 1995. Dendritic cells: a major story unfolds. Immunol. Today 16:330.
7. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
8. Bell, D., J. W. Young, and J. Banchereau. 1999. Dendritic cells. Adv. Immunol. 72:255.
9. Steinman, R. M., D. Hawiger, and M. C. Nussenzweig. 2003. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:685.
10. De Smedt, T., B. Pajak, E. Muraille, L. Lespagnard, E. Heinen, P. De Baetselier, J. Urbain, O. Leo, and M. Moser. 1996. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med. 184:1413.
11. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor α. J. Exp. Med. 179:1109.
12. Luft, T., K. C. Pang, E. Thomas, P. Hertzog, D. N. Hart, J. Trapani, and J. Cebon. 1998. Type 1 IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161:1947.
13. McBride, W. H., C.-S. Chiang, J. L. Olson, C.-C. Wang, J.-H. Hong, F. Pajonk, G. J. Dougherty, K. S. Iwamoto, M. Pervan, and Y.-P. Liao. 2004. A sense of danger from radiation, Radiat. Res. 162:1.
14. Pamer, E., and P. Cresswell. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16:323.
15. Guermonprez, P., J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20:621.
16. Rock, K. L., and A. L. Goldberg. 1999. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17:739.
17. Watts, C., and S. Amigorena. 2000. Antigen traffic pathways in dendritic cells. Traffic 1:312.
18. + T cell responses to infectious agents, tumors, transplants, and vaccines. Adv. Immunol. 73:1.
19. Heath, W. R., and F. R. Carbone. 2001. Cross-presentation in viral immunity and self-tolerance. Nat. Rev. Immunol. 1:126.
20. McBride, W. H., F. Pajonk, C. S. Chiang, and J. R. Sun. 2002. NF-κB, cytokines, proteasomes, and low-dose radiation exposure. Mil. Med. 167:66.
21. Pajonk, F., and W. H. McBride. 2001. Ionizing radiation affects 26S proteasome function and associated molecular responses, even at low doses. Radiother. Oncol. 59:203.
22. Butterfield, L. H., A. Ribas, V. B. Dissette, S. N. Amamani, H. T. Vu, D. Oseguera, H.-J. Wang, R. M. Elashoff, W. H. McBride, B. Mukherji, A. J. Cochran, et al. 2003. Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma. Clin. Cancer Res. 9:998.
23. Butterfield, L. H., S. M. Jilani, N. G. Chakraborty, L. A. Bui, A. Ribas, V. B. Dissette, R. Lau, S. C. Gamradt, J. A. Glaspy, W. H. McBride, et al. 1998. Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-I adenovirus. J. Immunol. 161:5607.
24. Ribas, A., L. H. Butterfield, W. H. McBride, S. M. Jilani, L. A. Bui, C. M. Vollmer, R. Lau, V. B. Dissette, B. Hu, A. Y. Chen, et al, 1997. Genetic immunization for the melanoma antigen MART-I/Melan-A using recombinant adenovirus-transduced murme dendritic cells. Cancer Res. 57:2865.
25. Ribas, A., L. H. Butterfield, B. Hu, V. B. Dissette, A. Y. Chen, A. Koh, S. N. Amamani, J. A. Glaspy, W. H. McBride, and J. S. Economou. 2000. Generation of T-cell immunity to a murine melanoma using MART-1-engineered dendritic cells. J. Immunanother. 23:59.
26. Ribas, A., L. H. Butterfield, W. H. McBride, V. B. Dissette, A. Koh, C. M. Vollmer, B. Hu, A. Y. Chen, J. A. Glaspy, and J. S. Economou. 1999. Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cells. Cancer Gene Ther. 6:523.
27. Hofbauer, G. F., J. Kamarashev, R. Geertsen, R. Boni, and R. Dummer. 1998. Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution. Melonoma Res. 8:337.
28. Kawakami, Y., S. Eliyahu, C. H. Delgado, P. F. Robbins, L. Rivoltini, S. L. Topalian, T. Miki, and S. A. Rosenberg. 1994. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA 91:3515.
29. Kawakami, Y., S. Eliyahu, K. Sakaguchi, P. F. Robbins, L. Rivoltini, J. R. Yannelli, E. Appella, and S. A. Rosenberg. 1994. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180:347.
30. Krausa, P., M. Brywka III, D. Savage, K. M. Hui, M. Bunce, J. L. Ngai, D. L. Teo, Y. W. Ong, D. Barouch, C. E. Allsop, et al. 1995. Genetic polymorphism within HLA-A*02: significant allelic variation revealed in different populations. Tissue Antigens 45:223.
31. + T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1. Int. J. Cancer 98:376.
32. Wang, F., E. Bade, C. Kuniyoshi, L. Spears, G. Jeffery, V. Marty, S. Groshen, and J. Weber. 1999. Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma. Clin. Cancer Res. 5:2756.
33. Hersey, P., S. W. Menzies, G. M. Halliday, T. Nguyen, M. L. Farrelly, C. DeSilva, and M. Lett. 2004. Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma. Cancer Immunol Immunother. 53:125.
34. Panelli, M. C., J. Wunderlich, J. Jeffries, E. Wang, A. Mixon, S. A. Rosenberg, and F. M. Marincola. 2000. Phase 1 study in patients with metastatic melanoma of immunization with dendritic cells presenting epitopes derived from the melanoma-associated antigens MART-1 and gp100. J. Immunother. 23:487.
35. Vitiello, A., D. Marchesini, J. Furze, L. A. Sherman, and R. W. Chesnut. 1991. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J. Exp. Med. 173:1007.
36. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
37. Irwin, M. J., W. R. Heath, and L. A. Sherman. 1989. Species-restricted interactions between CD8 and the α3 domain of class 1 influence the magnitude of the xenogeneic response. J. Exp. Med. 170:1091.
38. Zhai, Y., J. C. Yang, P. Spiess, M. I. Nishimura, W. W. Overwijk, B. Roberts, N. P. Restifo, and S. A. Rosenberg. 1997. Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MARTI and gp100. J. Immunother. 20:15.
39. Lutz, M. B., M. Schnare, M. Menges, S. Rossner, M. Rollinghoff, G. Schuler, and A. Gessner. 2002. Differential functions of IL-4 receptor types I and II for dendritic cell maturation and IL-12 production and their dependency on GM-CSF. J. Immunol. 169:3574.
40. Meng, W. S., L. H. Butterfield, A. Ribas, J. B. Heller, V. B. Dissette, J. A. Glaspy, W. H. McBride, and J. S. Economou. 2000. Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human a-fetoprotein. Mol. Immunol. 37:943.
41. Butterfield, L. H., A. Koh, W. Meng, C. M. Vollmer, A. Ribas, V. Dissette, E. Lee, J. A. Glaspy, W. H. McBride, and J. S. Economou. 1999. Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from α-fetoprotein. Cancer Res. 59:3134.
42. Wasserman, J., H. Blomgren, B. Petrini, E. Baral, L. E. Strender, C. Jarstrand, and L. V. von Stedingk. 1982. Effect of radiation therapy and in vitro x-ray exposure on lymphocyte subpopulations and their functions. Am J. Clin. Oncol. 5:195.
43. Wasserman, J., H. Blomgren, S. Rotstein, B. Petrini, and S. Hammarstrom. 1989. Immunosuppression in irradiated breast cancer patientsi in vitro effect of cyclooxygenase inhibitors. Bull. NY Acad. Med. 65:36.
44. Cole, S. 1986. Long-term effects of local ionizing radiation treatment on Langerhans cells in mouse footpad epidermis. J. Invest. Dermatol. 87:608.
45. James, R. F., S. P. Lake, J. Chamberlain, S. Thirdborough, P. D. Bassett, N. Mistry, and P. R. Bell. 1989. γ Irradiation of isolated rat islets pretransplantation produces indefinite allograft survival in cyclosporine-treated recipients. Transplantation 47:929.
46. Loftus, I. M., N. J. London, S. M. Thirdborough, P. R. Bell, and R. F. James. 1991. Isogeneic islet transplantation: the effect of γ irradiation. Transplantation 52:567.
47. Hauser, S. H., L. Calorini, D. E. Wazer, and S. Gattoni-Celli. 1993. Radiation-enhanced expression of major histocompatibility complex class I antigen H-2Db in B 16 melanoma cells. Cancer Res. 53:1952.
48. Seo, A., F. Ishikawa, H. Nakano, H. Nakazaki, K. Kobayashi, and T. Kakiuchi. 1999. Enhancement of B7-1 (CD80) expression on B-lymphoma cells by irradiation. Immunology 96:642.
49. Vereecque, R., G. Buffenoir, R. Gonzalez, N. Cambier, D. Hetuin, F. Bauters, P. Fenaux, and B. Quesnel. 2000. γ-Ray irradiation induces B7.1 expression in myelold leukemic cells. Br. J. Haematol. 108:825.
50. Ciemik, I. F., P. Romero, J. A. Berzofsky, and D. P. Carbone. 1999. Ionizing radiation enhances immunogenicity of cells expressing a tumor-specific T-cell epitope. Int. J. Radiat. Oncol. Biol. Phys. 45:735.
51. Cerundolo, V., A. Benham, V. Braud, S. Mukherjee, K. Gould, B. Macino, J. Neefjes, and A. Townsend. 1997. The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells. Eur. J. Immunol. 27:336.
52. Rock, K. L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A. L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761.
53. Wiertz, E. J., T. R. Jones, L. Sun, M. Bogyo, H. J. Geuze, and H. L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769.
54. Rube, C. E., F. van Valen, F. Wilfert, J. Palm, A. Schuck, N. Willich, W. Winkelmann, H. Jurgens, and C. Rube. 2003. Ewing's sarcoma and peripheral primitive neuroectodermal tumor cells produce large quantities of bioactive tumor necrosis factor-α after radiation exposure. Int. J. Radiat. Oncol. Biol. Phys. 56:1414.
55. Hallahan, D. E., D. R. Spriggs, M. A. Beckett, D. W. Kufe, and R. R. Weichselbaum. 1989. Increased tumor necrosis factor α mRNA after cellular exposure to ionizing radiation. Proc. Natl. Acad. Sci. USA 86:10104.
56. Chang, C. M., A. Limanni, W. H. Baker, M. E. Dobson, J. F. Kalinich, and M. L. Patchen. 1997. Sublethal γ irradiation increases IL-1α, IL-6, and TNF-α mRNA levels in murine hematopoietic tissues. J. Interferon Cytokine Res. 17:567.
57. Brach, M., H. Gruss, T. Kaisho, Y. Asano, T. Hirano, and F. Herrmann. 1993. Ionizing radiation induces expression of interleukin 6 by human fibroblasts involving activation of nuclear factor-κB. J. Biol. Chem. 268:8466.
58. Beetz, A., G. Messer, T. Oppel, D. van Beuningen, R. U. Peter, and P. Kind. 1997. Induction of interleukin 6 by ionizing radiation in a human epithelial cell line: control by corticosteroids. Int. J. Radiat. Biol. 72:33.
59. Broski, A. P., and P. F. Halloran. 1994. Tissue distribution of IL-10 mRNA in normal mice: evidence that a component of IL-10 expression is T and B cell-independent and increased by irradiation. Transplantation 57:582.
60. Nikitina, E. Y., and D. I. Gabrilovich. 2001. Combination of γ-irradiation and dendritic cell administration induces a potent antitumor response in tumor-bearing mice: approach to treatment of advanced stage cancer. Int. J. Cancer 94:825.
61. Teitz-Tennenbaum, S., Q. Li, S. Rynkiewicz, F. Ito, M. A. Davis, C. J. Mcginn, and A. E. Chang. 2003. Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration. Cancer Res. 63:8466.
62. Friedman, E. J. 2002. Immune modulation by ionizing radiation and its implications for cancer immunotherapy. Curr. Pharm. Des. 8:1765.
63. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991.
64. Matzinger, P. 2002. The danger model: a renewed sense of self. Science 296:301.
65. Matzinger, P. 2002. An innate sense of danger. Ann. NY Acad. Sci. 961:241: